medline.ch Respirationstrakt Neoplasie

	Impacts of (18)F-FDG PET/CT Parameters on Differential Diagnosis and Outcome of Patients with Primary Invasive Mucinous and Lepidic Predominant Adenocarcinoma of the Lung. Mol Imaging Radionucl Ther Tatc, Özmen Ö, K, Demira, Bilgiç S. PMID: 39373141 [PubMed]
	Whole slide image-based weakly supervised deep learning for predicting major pathological response in non-small cell lung cancer following neoadjuvant chemoimmunotherapy: a multicenter, retrospective, cohort study. Front Immunol Han D, Li H, Zheng X, Fu S, Wei R, Zhao Q, Liu C, Wang Z, Huang W, Hao S. PMID: 39372403 [PubMed - indexed for MEDLINE]
	Prognostic implications of tumor-infiltrating lymphocytes in non-small cell lung cancer: a systematic review and meta-analysis. Front Immunol Yan Q, Li S, He L, Chen N. PMID: 39372398 [PubMed - indexed for MEDLINE]
	Frequency of Depression and Anxiety in Patients With Lung Cancer Undergoing Chemotherapy: A Single-Center, Cross-Sectional Study From Vietnam. Cureus Thi Ngoc Han V, Thuy Vy H, Tat Bang H, Quoc Trung L, Thanh Vy T. PMID: 39371785 [PubMed]
	Landscape of C-MET overexpression in non-small cell lung cancer: a large-scale study of clinicomolecular features and prognosis based on Chinese data. Ther Adv Med Oncol Zhan S, Li J, Cheng B, Li C, Feng Y, Fan L, Xiong S, Zeng W, Cai Q, Xiang Y, Wang H, Li C, Chen P, Zheng X, Fu W, Hao Z, He J, Liang W. PMID: 39371619 [PubMed]
	Efficacy and safety of anlotinib plus penpulimab as second-line treatment for small cell lung cancer: A multicenter, open-label, single-arm phase II trial. Cancer Pathog Ther Zhang C, Chen J, Wu H, Wang J, Gao L, Zhao J, Sun Y, Jia Z, Mu X, Bai C, Wang R, Wu K, Liu Q, Shi Y. PMID: 39371104 [PubMed]
	The Interval of Computed Tomography Follow-Ups after Advanced Non-Small-Cell Lung Cancer Surgery Did Not Show Any Relationship with Survival. Ann Thorac Cardiovasc Surg Maru N, Hino H, Utsumi T, Matsui H, Taniguchi Y, Saito T, Murakawa T. PMID: 39370264 [PubMed - indexed for MEDLINE]
	A Response to the Letter to the Editor: "Comment on Stereotactic Body Radiotherapy for Centrally Located Inoperable Early Stage NSCLC: EORTC 22113-08113 LungTech Phase II Trial Results". J Thorac Oncol Levy A, Adebahr S, Hurkmans C, Fortpied C, Le Pechoux C, Faivre-Finn C, Nestle U. PMID: 39370228 [PubMed - indexed for MEDLINE]
	Comment on "Stereotactic Body Radiotherapy for Centrally Located Inoperable Early-Stage NSCLC: EORTC 22113-08113 LungTech Phase II Trial Results". J Thorac Oncol Xu Z, Jiang J, Guo H, Zhao D, Liu S. PMID: 39370227 [PubMed - indexed for MEDLINE]
	Impact of the Ninth International Association for the Study of Lung Cancer TNM Classification on Endobronchial Ultrasound for Lung Cancer Staging. J Thorac Oncol Faria N, Costa MI, Lacerda C, Sucena M. PMID: 39370225 [PubMed - indexed for MEDLINE]
	Long-Term Survival Outcomes With First-Line Nivolumab Plus Ipilimumab-Based Treatment in Patients With Metastatic Non-Small Cell Lung Cancer and Tumor PD-L1 <1%: a Pooled Analysis. J Thorac Oncol Peters S, Paz-Ares LG, Reck M, Carbone DP, Brahmer JR, Borghaei H, Lu S, O'Byrne KJ, John T, Ciuleanu TE, Schenker M, Caro RB, Nishio M, Cobo M, Lee JS, Zurawski B, Pluzanski A, Aoyama T, Tschaika M, Devas V, Grootendorst DJ, Ramalingam SS. PMID: 39369790 [PubMed - as supplied by publisher]
	Therapeutic potential of tumor-infiltrating lymphocytes in non-small cell lung cancer. Cancer Lett Plaugher DR, Childress AR, Gosser CM, Esoe DP, Naughton KJ, Hao Z, Brainson CF. PMID: 39369769 [PubMed - as supplied by publisher]
	Surgical and safety outcomes in patients with non-small cell lung cancer receiving neoadjuvant chemoimmunotherapy versus chemotherapy alone: A systematic review and meta-analysis. Cancer Treat Rev Aburaki R, Fujiwara Y, Chida K, Horita N, Nagasaka M. PMID: 39369455 [PubMed - as supplied by publisher]
	Deep learning-based characterization of pathological subtypes in lung invasive adenocarcinoma utilizing (18)F-deoxyglucose positron emission tomography imaging. BMC Cancer Wu D, Li Y, Zhou M, Gong F, Li J. PMID: 39369213 [PubMed - indexed for MEDLINE]
	Predictive value of ZFHX4 mutation for the efficacy of immune checkpoint inhibitors in non-small cell lung cancer and melanoma. Invest New Drugs Fu C, Gu H, Sun L, Wang Z, Zhang Q, Luo N, Chen D, Zhou T. PMID: 39369144 [PubMed - as supplied by publisher]
	Multiregional transcriptomic profiling provides improved prognostic insight in localized non-small cell lung cancer. NPJ Precis Oncol Li C, Nguyen TT, Li JR, Song X, Fujimoto J, Little L, Gumb C, Chow CB, Wistuba II, Futreal AP, Zhang J, Hubert SM, Heymach JV, Wu J, Amos CI, Zhang J, Cheng C. PMID: 39369068 [PubMed]
	Exosomal ncRNAs in liquid biopsies for lung cancer. Clin Chim Acta Sadique Hussain M, Gupta G, Ghaboura N, Moglad E, Hassan Almalki W, Alzarea SI, Kazmi I, Ali H, MacLoughlin R, Loebenberg R, Davies N, Kumar Singh S, Dua K. PMID: 39368685 [PubMed - as supplied by publisher]
	Proactive physical activity programs in lung cancer surgical patients at short and mid-term: A systematic review and meta-analysis. Patient Educ Couns Heredia-Ciuró A, Raya-Benítez J, Calvache-Mateo A, Martín-Núñez J, Cabrera-Martos I, López-López L, Valenza MC. PMID: 39368436 [PubMed - as supplied by publisher]
	Systematic review and network meta-analysis of lorlatinib with comparison to other anaplastic lymphoma kinase (ALK) tyrosine kinase inhibitors (TKIs) as first-line treatment for ALK-positive advanced non-smallcell lung cancer (NSCLC). Lung Cancer Ou SH, Kilvert H, Candlish J, Lee B, Polli A, Thomaidou D, Le H. PMID: 39368244 [PubMed - as supplied by publisher]
	Inadequate staging and excessive surveillance imaging: Evaluating the magnitude of benefit of targeted therapies in lung cancer. Eur J Cancer Benjamin DJ, Prasad V. PMID: 39368224 [PubMed - as supplied by publisher]

Artikel 1 - 20 / 142598

Seite 1 von 7130



		Zeitfenster

	Mediscope AG E-mail: info@mediscope.ch
	Disclaimer \| Datenschutzerklärung / Privacy Policy \| Werbung